Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 trial of onabotulinumtoxinA in Japanese children with urinary incontinence due to neurogenic detrusor overactivity
jRCTs031190132Phase 1Completed
- Start
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of botulinum toxin type A in detrusor hyperreflexia (DH). Primary endpoints: Dose limiting toxicity and Recommended dose. Started Sep 2020; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
detrusor hyperreflexia (DH)
Beyond the preview
Go deeper on jRCTs031190132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190132.